Contact this trialFirst, we need to learn more about you.
Growth Hormone Secretagogue Receptor Agonist
LUM-201 for Human Growth Hormone Deficiency
Recruiting1 awardPhase 2
Minneapolis, Minnesota
This trial is studying the growth response to a new drug, LUM-201, in children with GHD who have previously been treated with another growth hormone for 12 months.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.